Works matching IS 01435221 AND DT 2023 AND VI 137 AND IP 4

Down-regulation of ALDOB during metabolic reprogramming mediates malignant behavior in hepatocellular carcinoma and insensitivity to postoperative adjuvant transarterial chemoembolization.

Published in:

Clinical Science, 2023, v. 137, n. 4, p. 303, doi. 10.1042/CS20220661

By:

• Jing-Xuan Xu;
• Shui-Lin Qin;
• Hao-Wen Wei;
• Yuan-Yuan Chen;
• Yu-Chong Peng;
• Lu-Nan Qi

Publication type:

Article